The company again rejected IFM’s $7 billion takeover offer despite losing its chairman and scrapping a poison pill provision ...
Chairman Debbie Goodin is under pressure to resign after IFM Investors secured more than 50 per cent of Atlas Arteria.
The executive chairman of WiseTech has also told the board he ‘emphatically and unequivocally denies any involvement in or ...
IFM Investors has been slowly creeping control over Atlas Arteria through on-market stock purchases, finally crossing the 50% ownership mark.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
IFM Investors is nearing a 50% holding in Australia-listed toll road operator Atlas Arteria Ltd., ahead of the Thursday night ...
Capital Brief on MSN
Atlas Arteria chair Debbie Goodin steps down after IFM takes more than 50% interest
The news: Toll road operator Atlas Arteria’s chair Debbie Goodin will retire effective 7 July as IFM takes control of more ...
MALVERN, PA / ACCESSWIRE / December 2, 2024 / ifm efector, inc. (ifm), a leading provider of sensors, controls, and software for industrial automation, today announced the launch of its new moneo ...
Atlas Arteria ( (AU:ALX)) has issued an update. Diamond Infraco 1, a wholly owned subsidiary of IFM Global Infrastructure Fund, has confirmed that all regulatory approvals and other defeating ...
Bristol-Myers Squibb is to buy biotech IFM Therapeutics, and its potential new cancer immunotherapy technology, in a deal that could be worth more than $2.3 billion. BMS will gain rights to IFM’s ...
June 15 (Reuters) - IFM Global Infrastructure Fund sweetened its takeover bid for Australia's Atlas Arteria on Monday to A$7.40 billion ($5.24 billion), calling the revised offer its "best and final" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results